Dicerna Pharmaceuticals, Inc.
Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
Last updated:
Abstract:
This invention relates to compounds, compositions, and methods useful for reducing Glycolate Oxidase (HAO1) target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.
Status:
Grant
Type:
Utility
Filling date:
20 Aug 2019
Issue date:
13 Jul 2021